1. Phase I dose-escalating study of SU11654, a small molecule tyrosine kinase inhibitor in dogs with spontaneous malignancies;MORRIS, J.; LONDON, C.A.; HANNAH, A.L.; ZADOVOSKAYA, R.; CHIEN, M.B.; KOLLIAS-BAKER, C.; ROSENBERG, M.; DOWNING, S.; POST, G.; BOUCHER, J.; SHENOY, N.; MENDEL, D.B.; McMAHON, G.; CHERRINGTON, J.M.;Clinical Cancer Research; BSAVA Manual of Canine and Feline Haematology; Leukaemia,2003
2. Disorders of leucocytes;reading BLACKWOOD, Further; L.;BSAVA Manual of Canine and Feline Clinical; Veterinary Clinical Pathology; Detection of neoplastic lymphocytes in peripheral blood of dogs with lymphoma by polymerase chain reaction for antigen receptor gene rearrangement,2005